Europharma’s new analytical services manager is Dr Anna Kintner, who will be focusing on q16 and SuperSmolt.
Portable technology Q16 provides rapid diagnosis of pathogens in salmon tissue samples. The q16 testing encompasses a comprehensive list of diseases occurring in fish farms and the platform is now in use across Scotland. SuperSmolt is a feed programme for hatcheries that offers optimal smoltification of Atlantic salmon without any need for a winter photoperiod.
“In this field, you need to be ready to learn and create new techniques and solutions all the time, and work with to customers to make sure you’re addressing their needs,” said Dr Kintner, who has four years of experience in aquaculture.
She added: "I love that the job always brings new opportunities for innovation. It’s a great balance where I have my own lab to meet customers’ needs whilst still being able to investigate new technological avenues.”
ATPase transition
Nikos Steiropoulos, CEO of Europharma UK, added: “It’s an exciting time for us with a busy year ahead as the transition of the current ATPase analysis method onto a PCR ATPase biomarkers method already used in Europharma Norway - will also be one of the internal development projects that Anna is going to help us with."
As part of her PHD work, Dr Kintner conducted research focused on Australian box jellyfish venom toxicology and jellyfish population dynamics and their effects on salmon health.
